Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HPG-1860 by Hepagene Therapeutics Shanghai for Primary Biliary Cholangitis (Primary Biliary Cirrhosis): Likelihood of Approval
HPG-1860 is under clinical development by Hepagene Therapeutics Shanghai and currently in Phase I for Primary Biliary Cholangitis (Primary Biliary...
HPG-1860 by Hepagene Therapeutics Shanghai for Primary Sclerosing Cholangitis: Likelihood of Approval
HPG-1860 is under clinical development by Hepagene Therapeutics Shanghai and currently in Phase I for Primary Sclerosing Cholangitis. According to...
HPG-1860 by Hepagene Therapeutics Shanghai for Inflammatory Bowel Disease: Likelihood of Approval
HPG-1860 is under clinical development by Hepagene Therapeutics Shanghai and currently in Phase I for Inflammatory Bowel Disease. According to...